Chief Executive Officer & Founder Neurxstem
OCT 18, 2016 1:40 PM PDT
The Future of Science and Live Q&A
Presented at:
SyncD³ - Where drug discovery & development meet
Speakers
-
Richard Visconti, PhD
Cell Sciences Innovation, Merck Research Laboratories, Merck
You May Also Like
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
DEC 13, 2023 | 9:00 AM
The quest for digital excellence in today’s biotech research laboratories demands modern software acquisition, robust protection protocols, and a keen eye on evolving security requirem...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
OCT 24, 2023 | 10:00 AM
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
SEP 03, 2024Microbiology Week Virtual Event Series 2024
- See More
-
APR 18, 2024
- See More
